Novel Intraperitoneal Treatment With Non-Thermal Plasma-Activated Medium Inhibits Metastatic Potential of Ovarian Cancer Cells

Novel Intraperitoneal Treatment With Non-Thermal Plasma-Activated Medium Inhibits Metastatic Potential of Ovarian Cancer Cells

Abstract Non-thermal atmospheric pressure plasma has been proposed as a new therapeutic tool for cancer treatment. Recently, plasma-activated medium (PAM) has been widely studied in various cancer types. However, there are only few reports demonstrating the anti-tumour effects of PAM in an animal mo...

Full description

Bibliographic Details
Main Authors:	Kae Nakamura, Yang Peng, Fumi Utsumi, Hiromasa Tanaka, Masaaki Mizuno, Shinya Toyokuni, Masaru Hori, Fumitaka Kikkawa, Hiroaki Kajiyama
Format:	Article
Language:	English
Published:	Nature Portfolio 2017-07-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-017-05620-6

Similar Items

Preclinical Verification of the Efficacy and Safety of Aqueous Plasma for Ovarian Cancer Therapy
by: Kae Nakamura, et al.
Published: (2021-03-01)

Effect of indirect nonequilibrium atmospheric pressure plasma on anti-proliferative activity against chronic chemo-resistant ovarian cancer cells in vitro and in vivo.
by: Fumi Utsumi, et al.
Published: (2013-01-01)

Low temperature plasma irradiation products of sodium lactate solution that induce cell death on U251SP glioblastoma cells were identified
by: Hiromasa Tanaka, et al.
Published: (2021-09-01)

Novel ovarian endometriosis model causes infertility via iron-mediated oxidative stress in mice
by: Shotaro Hayashi, et al.
Published: (2020-10-01)

Met is the most frequently amplified gene in endometriosis-associated ovarian clear cell adenocarcinoma and correlates with worsened prognosis.
by: Yoriko Yamashita, et al.
Published: (2013-01-01)

Growing Teratoma Syndrome of the Ovary Showing Three Patterns of Metastasis: A Case Report
by: Kiyosumi Shibata, et al.
Published: (2013-11-01)

Fertility-Sparing surgery for young women with ovarian endometrioid carcinoma: a multicenteric comparative study using inverse probability of treatment weighting
by: Hiroaki Kajiyama, et al.
Published: (2019-10-01)

Fertility-sparing surgery and oncologic outcome among patients with early-stage ovarian cancer ~propensity score- matched analysis~
by: Hiroaki Kajiyama, et al.
Published: (2019-12-01)

Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells
by: Mizutani Shigehiko, et al.
Published: (2007-07-01)

Tetrachloroaurate (III)–induced oxidation increases nonthermal plasma-induced aldehydes
by: Yasumasa Okazaki, et al.
Published: (2023-12-01)

Extracellular miRNAs as Predictive Biomarkers for Glypican-3-Derived Peptide Vaccine Therapy Response in Ovarian Clear Cell Carcinoma
by: Mayu Ukai, et al.
Published: (2021-02-01)

Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer
by: Akira Yokoi, et al.
Published: (2017-03-01)

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
by: McKayla J. Riggs, et al.
Published: (2020-01-01)

Complete Response of Recurrent Small Cell Carcinoma of the Uterine Cervix to Paclitaxel, Carboplatin, and Bevacizumab Combination Therapy
by: Yuri Nakao, et al.
Published: (2020-04-01)

Aminopeptidase N (APN)/CD13 inhibitor, Ubenimex, enhances radiation sensitivity in human cervical cancer
by: Nawa Akihiro, et al.
Published: (2008-03-01)

Core 2 β1,6-N-acetylglucosaminyltransferases accelerate the escape of choriocarcinoma from natural killer cell immunity
by: Kenichi Nakamura, et al.
Published: (2021-07-01)

Improving intraperitoneal adenovirus virotherapy for ovarian cancer
by: Thoma, CMM
Published: (2011)

Targeting gene therapy to intraperitoneal ovarian carcinoma
by: Morrison, J
Published: (2006)

Microphthalmia-Associated Transcription Factor-Dependent Melanoma Cell Adhesion Molecule Activation Promotes Peritoneal Metastasis of Ovarian Cancer
by: Kazuhisa Kitami, et al.
Published: (2020-12-01)

P-LAP/IRAP-induced cell proliferation and glucose uptake in endometrial carcinoma cells via insulin receptor signaling
by: Nomura Seiji, et al.
Published: (2007-01-01)

Role of hyperthermic intraperitoneal chemotherapy in combination with an intraperitoneal port system in the treatment of patients with advanced ovarian cancer
by: V. V. Saevets, et al.
Published: (2022-01-01)

Mechanistic Insights on Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
by: Olivia G. Huffman, et al.
Published: (2023-02-01)

Heated Intraperitoneal Chemotherapy in the Management of Advanced Ovarian Cancer
by: Andrea Jewell, et al.
Published: (2018-09-01)

Hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer
by: Wei-Chun Chen, et al.
Published: (2022-10-01)

Intraperitoneal chemotherapy in the management of ovarian cancer: focus on carboplatin
by: Maurie Markman
Published: (2009-02-01)

Study on intraperitoneal chemotherapy in treatment of peritoneal metastatic colorectal cancer
by: CHENG Guozhu, CAI Guoxiang
Published: (2021-01-01)

Intraperitoneal delivery of paclitaxel by poly(ether-anhydride) microspheres effectively suppresses tumor growth in a murine metastatic ovarian cancer model
by: Wood, Joseph, et al.
Published: (2016)

Intraperitoneal biotherapy of malignant peritoneal effusions in ovarian cancer patients
by: К. S. Titov, et al.
Published: (2014-07-01)

Specific features of current intraperitoneal therapy in patients with ovarian cancer
by: A. G. Kedrova, et al.
Published: (2016-06-01)

An intraperitoneal implantable drug delivery device for the treatment of ovarian cancer
by: Ye, Hongye
Published: (2014)

Intraperitoneal splenosis mimics peritoneal carcinomatosis of leiomyosarcoma and ovarian cancer
by: Yu-Chien Lin, et al.
Published: (2020-09-01)

Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy
by: Chua TC, et al.
Published: (2012-11-01)

Metastatic Voyage of Ovarian Cancer Cells in Ascites with the Assistance of Various Cellular Components
by: Kaname Uno, et al.
Published: (2022-04-01)

Intraperitoneal chemotherapy following refractory intravenous route in advanced ovarian cancer.
by: Shafiee MN,, et al.
Published: (2013)

Chemotherapy-Eluting Intraperitoneal Implants for Advanced Stage Ovarian Cancer Treatment
by: Subramanyam, Kriti S.
Published: (2022)

Design of an intraperitoneal drug-release device for advanced ovarian cancer therapy
by: Tanenbaum, Laura Melanie
Published: (2016)

Pedunculated Intraperitoneal Lipoma Presenting as Ovarian Torsion: A Case Report
by: Vijayalakshmi Kandasamy, et al.
Published: (2022-04-01)

Carrier-free multifunctional nanomedicine for intraperitoneal disseminated ovarian cancer therapy
by: Xiuyu Huang, et al.
Published: (2022-02-01)

Assessment of travel distance for hyperthermic intraperitoneal chemotherapy in women with ovarian cancer
by: Laura M. Chambers, et al.
Published: (2022-04-01)

Intraperitoneal Rupture of Mature Cystic Ovarian Teratoma Secondary to Sit-ups
by: Yu-Tang Chang, et al.
Published: (2009-02-01)